Jeremy G. Chadwick, Senior VP, Pgm Management and Clin Operations at SYNTA PHARMACEUTICALS CORP (SNTA), sold 4,573 shares at $6.20 ($28K) on 2009-01-05, disclosed to the SEC on 2009-01-06.
Scheduled sale ($28k) by Senior VP, Pgm Management and Clin Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KYMR | SELL | 2026-04-16 | $590K | — | Filing → |
| KYMR | SELL | 2026-04-01 | $1.9M | — | Filing → |
| KYMR | SELL | 2026-03-25 | $18.0M | — | Filing → |